DE3884304D1 - Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe. - Google Patents
Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe.Info
- Publication number
- DE3884304D1 DE3884304D1 DE88306584T DE3884304T DE3884304D1 DE 3884304 D1 DE3884304 D1 DE 3884304D1 DE 88306584 T DE88306584 T DE 88306584T DE 3884304 T DE3884304 T DE 3884304T DE 3884304 D1 DE3884304 D1 DE 3884304D1
- Authority
- DE
- Germany
- Prior art keywords
- isosteres
- purines
- hypoglycemic agents
- piperazinyl derivatives
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/24—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one nitrogen and one sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/40—Heterocyclic compounds containing purine ring systems with halogen atoms or perhalogeno-alkyl radicals directly attached in position 2 or 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic System
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/0803—Compounds with Si-C or Si-Si linkages
- C07F7/081—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te
- C07F7/0812—Compounds with Si-C or Si-Si linkages comprising at least one atom selected from the elements N, O, halogen, S, Se or Te comprising a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/16—Purine radicals
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US7536287A | 1987-07-20 | 1987-07-20 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3884304D1 true DE3884304D1 (de) | 1993-10-28 |
| DE3884304T2 DE3884304T2 (de) | 1994-03-24 |
Family
ID=22125206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE88306584T Expired - Fee Related DE3884304T2 (de) | 1987-07-20 | 1988-07-19 | Piperazinylderivate von Purinen und deren Isostere als hypoglykämische Wirkstoffe. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0300726B1 (de) |
| JP (1) | JP2562181B2 (de) |
| KR (1) | KR890002155A (de) |
| AT (1) | ATE94877T1 (de) |
| AU (1) | AU601862B2 (de) |
| CA (1) | CA1341043C (de) |
| DE (1) | DE3884304T2 (de) |
| DK (1) | DK403188A (de) |
| ES (1) | ES2058291T3 (de) |
| FI (1) | FI883423A (de) |
| HU (1) | HU199144B (de) |
| IL (1) | IL87149A (de) |
| NO (1) | NO167203C (de) |
| NZ (1) | NZ225447A (de) |
| PT (1) | PT88029B (de) |
| YU (1) | YU46761B (de) |
| ZA (1) | ZA885242B (de) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL86007A0 (en) * | 1987-04-09 | 1988-09-30 | Wellcome Found | 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them |
| GB8716313D0 (en) * | 1987-07-10 | 1987-08-19 | Janssen Pharmaceutica Nv | 2-(heterocyclylalkyl)imidazopyridines |
| GB8922076D0 (en) * | 1989-09-28 | 1989-11-15 | Beecham Group Plc | Novel process |
| DK150591D0 (da) * | 1991-08-26 | 1991-08-26 | Novo Nordisk As | Kemisk forbindelse |
| US5583137A (en) * | 1992-02-19 | 1996-12-10 | Pfizer Inc. | Heterocyclic compounds for enhancing antitumor activity |
| US5864037A (en) * | 1996-06-06 | 1999-01-26 | Euro-Celtique, S.A. | Methods for the synthesis of chemical compounds having PDE-IV inhibitory activity |
| EP1067123B1 (de) | 1998-03-31 | 2011-01-19 | Kyowa Hakko Kirin Co., Ltd. | Stickstoffenthaltende heterocyclische verbindungen |
| AU2003222786A1 (en) * | 2002-04-18 | 2003-10-27 | Ucb, S.A. | Chemical compounds with dual activity, processes for their preparation and pharmaceutical compositions |
| GB0215293D0 (en) | 2002-07-03 | 2002-08-14 | Rega Foundation | Viral inhibitors |
| NZ540495A (en) * | 2002-12-04 | 2007-09-28 | Eisai R&D Man Co Ltd | 1,3-Dihydro-imidazole fused-ring compound |
| US7772188B2 (en) | 2003-01-28 | 2010-08-10 | Ironwood Pharmaceuticals, Inc. | Methods and compositions for the treatment of gastrointestinal disorders |
| CA2537230A1 (en) | 2003-09-05 | 2005-03-17 | Altana Pharma Ag | Use of pde4 inhibitors for the treatment of diabetes mellitus |
| JP4970048B2 (ja) | 2003-12-22 | 2012-07-04 | カトリーケ・ウニフェルジテイト・ルーベン・カー・イュー・ルーベン・アール・アンド・ディ | イミダゾ［４，５−ｃ］ピリジン化合物および抗ウイルス治療の方法 |
| EP1756093A1 (de) | 2004-06-17 | 2007-02-28 | Wyeth | Herstellungsverfahren für gonadotropin-freisetzende hormonrezeptor-antagonisten |
| KR20070027584A (ko) | 2004-06-17 | 2007-03-09 | 와이어쓰 | 고나도트로핀 방출 호르몬 수용체 길항제 |
| PL1841765T3 (pl) | 2004-12-21 | 2009-08-31 | Gilead Sciences Inc | Związek imidazo[4,5-c]pirydyny i sposób leczenia przeciwwirusowego |
| US7582634B2 (en) | 2005-02-18 | 2009-09-01 | Wyeth | 7-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7538113B2 (en) | 2005-02-18 | 2009-05-26 | Wyeth | 4-substituted imidazo[4,5-c]pyridine antagonists of gonadotropin releasing hormone receptor |
| US7534796B2 (en) | 2005-02-18 | 2009-05-19 | Wyeth | Imidazo[4,5-b]pyridine antagonists of gonadotropin releasing hormone receptor |
| JP5091106B2 (ja) | 2005-03-08 | 2012-12-05 | ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング | 真性糖尿病の治療のためのロフルミラスト |
| US7531542B2 (en) | 2005-05-18 | 2009-05-12 | Wyeth | Benzooxazole and benzothiazole antagonists of gonadotropin releasing hormone receptor |
| US7582636B2 (en) | 2005-05-26 | 2009-09-01 | Wyeth | Piperazinylimidazopyridine and piperazinyltriazolopyridine antagonists of Gonadotropin Releasing Hormone receptor |
| ES2339298T3 (es) | 2006-07-07 | 2010-05-18 | Gilead Sciences, Inc. | Compuesto de piridazina novedoso y uso del mismo. |
| AU2008261102B2 (en) | 2007-06-04 | 2013-11-28 | Bausch Health Ireland Limited | Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| US8969514B2 (en) | 2007-06-04 | 2015-03-03 | Synergy Pharmaceuticals, Inc. | Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases |
| UA99466C2 (en) | 2007-07-06 | 2012-08-27 | Гилиад Сайенсиз, Инк. | Crystalline pyridazine compound |
| EP2810951B1 (de) | 2008-06-04 | 2017-03-15 | Synergy Pharmaceuticals Inc. | Für die Behandlung von gastrointestinalen Erkrankungen, Entzündungen, Krebs und anderen Erkrankungen geeignete Agonisten von Guanylatcyclase |
| EP2307414A4 (de) * | 2008-07-07 | 2011-10-26 | Xcovery Holding Co Llc | Selektive pi3k-isoform-hemmer |
| ES2624828T3 (es) | 2008-07-16 | 2017-07-17 | Synergy Pharmaceuticals Inc. | Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros |
| UA104010C2 (en) | 2008-12-18 | 2013-12-25 | Эли Лилли Энд Компани | Purine compounds |
| JP5647998B2 (ja) * | 2009-03-13 | 2015-01-07 | カトリーケ ユニバーシテイト ルーヴェン、ケー．ユー． ルーヴェン アール アンド ディー | 免疫抑制剤としてのチアゾロピリミジン調節因子 |
| AR080711A1 (es) | 2010-03-31 | 2012-05-02 | Lilly Co Eli | Compuesto de piperazin-purina composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para el tratamiento o prevencion del dolor |
| ES2481867T3 (es) | 2010-03-31 | 2014-07-31 | Eli Lilly And Company | Compuestos de purina usados como agonistas de CB2 |
| US9616097B2 (en) | 2010-09-15 | 2017-04-11 | Synergy Pharmaceuticals, Inc. | Formulations of guanylate cyclase C agonists and methods of use |
| CN107090016A (zh) | 2011-03-01 | 2017-08-25 | 辛纳吉制药公司 | 制备鸟苷酸环化酶c激动剂的方法 |
| EP3718557A3 (de) | 2013-02-25 | 2020-10-21 | Bausch Health Ireland Limited | Guanylat-cyclase-rezeptoragonist sp-333 zur verwendung in der darmreinigung |
| WO2014151200A2 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Compositions useful for the treatment of gastrointestinal disorders |
| CA2905438A1 (en) | 2013-03-15 | 2014-09-25 | Synergy Pharmaceuticals Inc. | Agonists of guanylate cyclase and their uses |
| CA2903588C (en) * | 2013-05-02 | 2021-10-26 | F. Hoffmann-La Roche Ag | Purine derivatives as cb2 receptor agonists |
| KR102272746B1 (ko) | 2013-06-05 | 2021-07-08 | 보슈 헬스 아일랜드 리미티드 | 구아닐레이트 사이클라제 c의 초순수 작용제, 및 이의 제조 및 사용 방법 |
| EP3030252B1 (de) | 2013-08-09 | 2018-11-07 | Ardelyx, Inc. | Verbindungen und verfahren zur hemmung eines phosphattransports |
| CN104497085B (zh) * | 2015-01-16 | 2017-05-24 | 华东理工大学 | 腺苷衍生物及其用途 |
| US20200368223A1 (en) | 2019-05-21 | 2020-11-26 | Ardelyx, Inc. | Methods for inhibiting phosphate transport |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1115260B (de) * | 1957-02-27 | 1961-10-19 | Thomae Gmbh Dr K | Verfahren zur Herstellung von Purinderivaten |
| GB1186504A (en) * | 1966-10-15 | 1970-04-02 | Fisons Pest Control Ltd | Substituted Heterocyclic Compounds |
| JPS60260579A (ja) * | 1984-01-13 | 1985-12-23 | Yoshitomi Pharmaceut Ind Ltd | プリン誘導体 |
| JPS6210085A (ja) * | 1985-07-05 | 1987-01-19 | Yoshitomi Pharmaceut Ind Ltd | トリフルオロメチルプリン誘導体 |
-
1988
- 1988-07-18 NZ NZ225447A patent/NZ225447A/en unknown
- 1988-07-18 IL IL8714988A patent/IL87149A/xx unknown
- 1988-07-19 NO NO883204A patent/NO167203C/no unknown
- 1988-07-19 EP EP88306584A patent/EP0300726B1/de not_active Expired - Lifetime
- 1988-07-19 AU AU19230/88A patent/AU601862B2/en not_active Ceased
- 1988-07-19 DK DK403188A patent/DK403188A/da not_active Application Discontinuation
- 1988-07-19 CA CA000572450A patent/CA1341043C/en not_active Expired - Fee Related
- 1988-07-19 PT PT88029A patent/PT88029B/pt not_active IP Right Cessation
- 1988-07-19 DE DE88306584T patent/DE3884304T2/de not_active Expired - Fee Related
- 1988-07-19 FI FI883423A patent/FI883423A/fi not_active Application Discontinuation
- 1988-07-19 HU HU883774A patent/HU199144B/hu not_active IP Right Cessation
- 1988-07-19 ES ES88306584T patent/ES2058291T3/es not_active Expired - Lifetime
- 1988-07-19 AT AT88306584T patent/ATE94877T1/de not_active IP Right Cessation
- 1988-07-20 JP JP63179325A patent/JP2562181B2/ja not_active Expired - Fee Related
- 1988-07-20 KR KR1019880009044A patent/KR890002155A/ko not_active Application Discontinuation
- 1988-07-20 YU YU141088A patent/YU46761B/sh unknown
- 1988-07-20 ZA ZA885242A patent/ZA885242B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU46761B (sh) | 1994-05-10 |
| NO883204D0 (no) | 1988-07-19 |
| ATE94877T1 (de) | 1993-10-15 |
| FI883423A0 (fi) | 1988-07-19 |
| NZ225447A (en) | 1991-12-23 |
| NO883204L (no) | 1989-01-23 |
| NO167203C (no) | 1991-10-16 |
| AU1923088A (en) | 1989-01-27 |
| ES2058291T3 (es) | 1994-11-01 |
| IL87149A (en) | 1994-05-30 |
| KR890002155A (ko) | 1989-04-08 |
| IL87149A0 (en) | 1988-12-30 |
| YU141088A (en) | 1990-10-31 |
| JP2562181B2 (ja) | 1996-12-11 |
| NO167203B (no) | 1991-07-08 |
| JPH01104074A (ja) | 1989-04-21 |
| HUT47575A (en) | 1989-03-28 |
| HU199144B (en) | 1990-01-29 |
| CA1341043C (en) | 2000-07-04 |
| AU601862B2 (en) | 1990-09-20 |
| DK403188D0 (da) | 1988-07-19 |
| PT88029B (pt) | 1995-03-01 |
| DE3884304T2 (de) | 1994-03-24 |
| EP0300726B1 (de) | 1993-09-22 |
| DK403188A (da) | 1989-03-30 |
| FI883423A (fi) | 1989-01-21 |
| ZA885242B (en) | 1989-03-29 |
| EP0300726A1 (de) | 1989-01-25 |
| PT88029A (pt) | 1989-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE94877T1 (de) | Piperazinylderivate von purinen und deren isostere als hypoglykaemische wirkstoffe. | |
| HUP0002373A2 (hu) | Glükagon antagonisták/inverz agonisták és ezeket tartalmazó gyógyászati készítmények | |
| DK642587D0 (da) | Insulinpraeparat | |
| DE3785684T2 (de) | Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung. | |
| ATE204178T1 (de) | Methode zur behandlung und vorbeugung von typ-1 diabetis durch orale verabreichung von insulin | |
| BE904421A (fr) | Derives heterocycliques aromatiques et leur application dans les domaines therapeutique et cosmetique. | |
| DE3686483T2 (de) | Arzneimittel. | |
| ATE62414T1 (de) | Mittel zur behandlung von herzerkrankungen. | |
| DE68906609T2 (de) | Dopamin-vorlaeufer. | |
| NO166939C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive carboxylsyrederivater. | |
| SE8600658D0 (sv) | Novel composition of matter | |
| ATE183648T1 (de) | Arzneimittel enthaltend mischungen von höheren primären aliphatischen alkoholen zur behandlung von hypercholesterolämie und hyperlipoproteinämie typ ii und zur stimulation des sexuellen verhaltens bei tieren und menschen | |
| DE58902582D1 (de) | Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe. | |
| ATE5256T1 (de) | Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel. | |
| KR890006665A (ko) | 항-hiv 활성, 3'-아지도-2,6-디아미노푸린-2',3'-디데옥시리보사이드 | |
| ATE75399T1 (de) | Therapeutikum zur behandlung von magengeschwueren. | |
| DK0402208T3 (da) | Sammensætning af vitamin A i fysiologisk dosis og forskellige aktive bestanddele med en terapeutisk aktivitet | |
| DE69211743D1 (de) | Aureobasidin enthaltendes Arzneimittel | |
| DE69008282D1 (de) | Kaffeesäure-Derivate, deren Verwendung für medizinische Behandlungen und diese enthaltende pharmazeutische Zusammensetzungen. | |
| DE3484155D1 (de) | Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216. | |
| ATE175349T1 (de) | Verwendung von etofibrat und pharmazeutische zusammensetzungen, enthaltend etofibrat, zur behandlung der diabetischen angio- und retinopathie | |
| ATE89000T1 (de) | Pyrrolidinamid-derivate von acylaminosaeure, pharmazeutische zusammensetzung und verwendung. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |